» Articles » PMID: 9629512

Endoscopic Ductal Drainage May Avoid Resective Surgery in Painful Chronic Pancreatitis Without Large Ductal Dilatation

Overview
Specialty Gastroenterology
Date 1998 Jun 18
PMID 9629512
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Conclusion: Endoscopic stenting treatment, in cases of chronic pancreatitis unsuitable for decompressive surgery, appears to be safe and efficient. Perfect anatomical results are only obtained if large stents are used after balloon dilatation.

Background: Decompressive surgery in cases of painful chronic pancreatitis is only feasible if the main pancreatic duct exceeds approx 8 mm over a sufficient length. When those anatomical changes are not present, surgery must be resective. This study evaluates the results of endoscopic stent drainage and decompression of painful chronic pancreatitis without large dilatation of the main pancreatic duct.

Methods: Sixteen of our chronic pancreatitis patients were included in this study. They presented a mean of 5.3 episodes of pain in the 6 mo before treatment. Decompressive surgery was not possible because of a mean pancreatic duct diameter of 5.8 mm. Stents were 7F in eight patients and 12F in the other eight. They were left in the duct after endoscopic dilation for 9.5 +/- 1.0 mo.

Results: During stenting we observed two early obstructions and seven episodes of pain. All cysts disappeared and stenosis of the duct disappeared anatomically in six cases, was improved in four, but persisted in six. During follow-up, two episodes of mild pain were recorded. No cysts reappeared. Complete disappearance of stenosis was only observed in patients whose pancreatic duct was equipped with a 12F stent (p < 0.02).

Citing Articles

Clinical Profile, Etiology and Role of Endotherapy in Chronic Calcific Pancreatitis: An Experience from North India.

Yattoo G, Mushfiq S, Kaushik S, Dar G, Parveen S, Dhar N Middle East J Dig Dis. 2023; 15(3):190-195.

PMID: 38023463 PMC: 10660324. DOI: 10.34172/mejdd.2023.343.


Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report.

Soyturk M, Bengi G, Oguz D, Kalkan I, Yalniz M, Tahtaci M Turk J Gastroenterol. 2020; 31(Supp1):S1-S41.

PMID: 33210608 PMC: 7752168. DOI: 10.5152/tjg.2020.220920.


Endoscopic management of chronic pancreatitis.

Oza V, Kahaleh M World J Gastrointest Endosc. 2013; 5(1):19-28.

PMID: 23330050 PMC: 3547116. DOI: 10.4253/wjge.v5.i1.19.


Endoscopic treatment of the main pancreatic duct: correlations among morphology, manometry, and clinical follow-up.

Renou C, Grandval P, Ville E, Laugier R Int J Pancreatol. 2000; 27(2):143-9.

PMID: 10862513 DOI: 10.1385/IJGC:27:2:143.

References
1.
Widdison A, Alvarez C, Karanjia N, Reber H . Experimental evidence of beneficial effects of ductal decompression in chronic pancreatitis. Endoscopy. 1991; 23(3):151-4. DOI: 10.1055/s-2007-1010645. View

2.
Kozarek R . Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc. 1990; 36(2):93-5. DOI: 10.1016/s0016-5107(90)70958-3. View

3.
Smits M, Rauws E, Tytgat G, Huibregtse K . The efficacy of endoscopic treatment of pancreatic pseudocysts. Gastrointest Endosc. 1995; 42(3):202-7. DOI: 10.1016/s0016-5107(95)70092-7. View

4.
Durbec J, SARLES H . Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption. Digestion. 1978; 18(5-6):337-50. DOI: 10.1159/000198221. View

5.
Catalano M, GEENEN J, Schmalz M, Johnson G, Dean R, Hogan W . Treatment of pancreatic pseudocysts with ductal communication by transpapillary pancreatic duct endoprosthesis. Gastrointest Endosc. 1995; 42(3):214-8. DOI: 10.1016/s0016-5107(95)70094-3. View